Drug Type CAR-T |
Synonyms- |
Target |
Mechanism EphA2 modulators(Ephrin type-A receptor 2 modulators), PDL1 modulators(Programmed death-ligand 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | KR | 17 Jun 2024 |